Dipeptidyl Peptidase IV Inhibitors for Management of Type 2 Diabetes

This book provides detailed summary about Dipeptidyl Peptidase IV (DPP IV) Inhibitors in Management of Type 2 Diabetes. DPP IV inhibitors are established therapy for managing blood glucose in patients with type 2 diabetes. Several DPP IV inhibitors are developed in last few years and are used clinically all over the world. This book describes role of Glucagon Like Peptide-1 (GLP-1), an incretin hormone in insulin secretion and how DPP IV inhibitors affect action of GLP-1. It is followed by chemistry of DPP IV inhibitors and their lead optimization strategies for clinical development.

Autorentext
Dr. Jagatkumar Upadhyay have more than 10 years of academic experience and 3 years of research experience in Drug Discovery Research. His research areas include computer-aided drug design techniques, synthesis of heterocyclic compounds and green chemistry.